A new diketopiperazine-like inhibitor of bone morphogenetic protein-induced osteoblastic differentiation produced by marine-derived Aspergillus sp. BFM-0085

J Antibiot (Tokyo). 2020 Aug;73(8):554-558. doi: 10.1038/s41429-020-0316-3. Epub 2020 May 21.

Abstract

A new diketopiperazine-like compound, designated protuboxepin K (1), was isolated together with the known structurally related protuboxepin A (2) from culture broth of the marine-derived fungal strain Aspergillus sp. BFM-0085 isolated from a sediment sample of Tokyo Bay. The structure of protuboxepin K was elucidated by spectroscopic data, including 1D and 2D NMR. Compounds 1 and 2 inhibited bone morphogenetic protein (BMP)-induced alkaline phosphatase activity with IC50 values of 4.7 and 25.2 μM, respectively, in mutant BMP receptor-carrying C2C12(R206H) cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aquatic Organisms / chemistry*
  • Aspergillus / chemistry*
  • Bone Morphogenetic Proteins / antagonists & inhibitors*
  • Cell Differentiation / drug effects*
  • Cell Line
  • Diketopiperazines / pharmacology*
  • Mice
  • Osteoblasts / drug effects*
  • Osteoblasts / metabolism

Substances

  • Bone Morphogenetic Proteins
  • Diketopiperazines